---
title: "Clarivate Reports Second Quarter 2026 Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294192381.md"
description: "LONDON, July 29, 2026 - Significant advancements have been made in the strategic and financial objectives through the implementation of the Value Creation Plan. The focus has been refined and the financial profile has been improved with the recent divestiture of the Life Sciences & Healthcare segment. The outlook for 2026 has been reinforced, demonstrating a positive trajectory for the future."
datetime: "2026-07-29T10:20:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294192381.md)
  - [en](https://longbridge.com/en/news/294192381.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294192381.md)
generator: "portal-rs"
---

# Clarivate Reports Second Quarter 2026 Results

LONDON, July 29, 2026 - Significant advancements have been made in the strategic and financial objectives through the implementation of the Value Creation Plan. The focus has been refined and the financial profile has been improved with the recent divestiture of the Life Sciences & Healthcare segment. The outlook for 2026 has been reinforced, demonstrating a positive trajectory for the future.

### Related Stocks

- [CLVT.US](https://longbridge.com/en/quote/CLVT.US.md)

## Related News & Research

- [Impiricus Launches QPharma® Integration to Power Real-Time Compliant HCP Sampling](https://longbridge.com/en/news/296957896.md)
- [BUZZ-Qiagen names Filtration Group's Pratt as CEO; shares down](https://longbridge.com/en/news/296802930.md)
- [Lumexa Imaging CEO, CFO to join Wells Fargo healthcare conference fireside chat](https://longbridge.com/en/news/296901710.md)
- [Ameriprise Financial declares Q3 2026 dividend of R$ 1.48 per unit](https://longbridge.com/en/news/297021432.md)
- [Cemat publishes H1 2026 interim report](https://longbridge.com/en/news/297006906.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**